Processed Residual Pump Blood in Cardiac Surgery: The PRBC Trial
PRBC
1 other identifier
interventional
200
1 country
1
Brief Summary
The study is an randomized controlled trial (RCT) of 198 coronary artery bypass graft (CABG) patients, exploring whether ultrafiltration of residual blood in the cardiopulmonary bypass circuit reduces transfusion and bleeding.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2004
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 1, 2004
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 16, 2010
CompletedFirst Posted
Study publicly available on registry
August 2, 2010
CompletedAugust 2, 2010
July 1, 2010
2.3 years
July 16, 2010
July 30, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
the proportion of patients transfused with homologous red blood cells (RBC)
At 30 days post-operatively
Secondary Outcomes (5)
Proportion of patients transfused with any blood product
At 30 days post-operatively
Volume of pRBC's transfused post-operative
At 30 days post-operatively
Post-operative hemorrhage
At 24 hours post-operative
Discharge Hemoglobin
A date of discharge, median 5 days in study
Length of hospital stay
From day to surgery to discharge, median 5 days in this study
Study Arms (2)
Treatment group
EXPERIMENTALUltra filtration of residual blood.
Control
NO INTERVENTIONThe current practice in our institution was to displace all the remaining volume in the CPB circuit into a transfer pack by displacing the remaining blood in the CPB circuit with additional Lactated Ringers solution. This transfer pack is then given to the anesthetist for reinfusion into the patient.
Interventions
The inflow line to the hemoconcentrator was connected to the sideport of the arterial filter stopcock, allowing the residual blood in the CPB circuit to be processed through the hemoconcentrator. The outflow line from the hemoconcentrator was connected to a second three way stopcock located on the cardiotomy reservoir. Blood was circulated from the venous reservoir through the hemoconcentrator and returned to the venous reservoir until the desired hematocrit was achieved. The blood was then diverted to a transfer pack until all the blood from the venous reservoir, heat exchanger, and membrane oxygenator had been filtered and hemoconcentrated. This transfer pack was given to the anesthetist for reinfusion into the patient.
Eligibility Criteria
You may qualify if:
- at least 18 years of age
- were to undergo isolated on-pump CABG
- were able to give informed consent
You may not qualify if:
- performed autologous blood donation
- underwent off-pump CABG
- emergency procedure
- resternotomy
- known bleeding disorder not drug related
- history of heparin-induced thrombocytopenia
- Jehovah's Witness
- intra-operative catastrophe prior to randomization
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hamilton General Hospital
Hamilton, Ontario, L8L2X2, Canada
Related Publications (1)
Whitlock R, Mathew J, Eikelboom J, Al-Saleh AM, Yuan F, Teoh K. Processed residual pump blood in cardiac surgery: the Processed Residual Blood in Cardiac surgery trial. Transfusion. 2013 Jul;53(7):1487-92. doi: 10.1111/j.1537-2995.2012.03958.x. Epub 2012 Nov 26.
PMID: 23176311DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Whitlock, MD MSc
Hamilton Health Sciences Corporation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 16, 2010
First Posted
August 2, 2010
Study Start
December 1, 2004
Primary Completion
April 1, 2007
Study Completion
April 1, 2007
Last Updated
August 2, 2010
Record last verified: 2010-07